Commemorative Series No. 2 · The Drug Money
OUTSPENTNo. 42/54
Byron
Dorgan
U.S. Senate · D-ND
Taken from pharma & insurers
$14,215
H.R.1 · Medicare drug-price ban · 2003tap to flip ⤺
WHO THEY WORK FORNo. 42/54
Pharma & Health$14,215
Banned Medicare from negotiating drug prices for 19 years. Once it could (2024), prices fell 38–79%. · 108-1-459OUTSPENT
Card 42 of 54 · tap the card to see who they work for
Beyond the check
The check is only the part you can see.
They took
$14,215
The industry spent on the bill
$116M
on drug-industry lobbying in 2003, about ten lobbyists for every senator
Through the leadership PAC
Beyond the campaign account, a leadership PAC under Dorgan's control (Great Plains Leadership Fund) took $51,500 from banks, drug makers and insurers.
Source: FEC; Great Plains Leadership Fund
The industry figure is lobbying spent on the bill, not a payment to this senator. Source: Public Citizen (2004); Center for Public Integrity. Everything here is documented public record; nothing alleges an illegal act.
Don't recognize a logo? Here's the key.
Pharma & Health$14,215
Johnson & Johnson$14,065
Merck$150